NBP
NovaBridge Biosciences
NASDAQ · USHealthcareBiotechnology
$1.82+2.25%
Price as of Jul 20, 2026
NBP ownership
NovaBridge Biosciences ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
90/100
Buys (3m)
1
Sells (3m)
4
Net (3m)
$511.4K
Insiders buying
Insider trades by month Buys Sells
Apr
May
Jun
Jul
Context3-month price -26.8%
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | Lin Liwei Lorraineofficer: General Counsel | Grant | 254,780 | $1.93 |
| Jul 10, 2026 | Hagler Mark Arnoldofficer: Chief Commercial Officer | Grant | 949,050 | $1.93 |
| Jul 8, 2026 | Gupta Srishtidirector, officer: Chief Executive Officer | Grant | 3,000,000 | $2.01 |
| Jul 7, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Sell | 4,485 | $0.89 |
| Jul 7, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Option | 5,405 | — |
| Jul 7, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Option | 12,432 | — |
| Jun 30, 2026 | Fu Weidirector | Grant | 1,087,720 | $2.45 |
| Jun 30, 2026 | Fu Weidirector | Grant | 1,010,100 | — |
| Jun 30, 2026 | Fu Weidirector | Grant | 725,140 | $2.45 |
| Jun 24, 2026 | Cao Sean Wuxiongdirector, officer: Chief Bus. Development Officer | Grant | 181,290 | $1.53 |
| Jun 24, 2026 | Cao Sean Wuxiongdirector, officer: Chief Bus. Development Officer | Grant | 181,280 | — |
| Jun 22, 2026 | Dennis Phillip Andrewofficer: Chief Medical Officer | Option | 10,302 | — |
| Jun 22, 2026 | Dennis Phillip Andrewofficer: Chief Medical Officer | Sell | 8,494 | $0.66 |
| Jun 22, 2026 | Dennis Phillip Andrewofficer: Chief Medical Officer | Option | 23,695 | — |
| Jun 2, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Option | 4,079 | — |
| Jun 2, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Sell | 3,494 | $3.94 |
| Jun 2, 2026 | Xu Cong Claireofficer: SVP, Clinical Development | Option | 9,382 | — |
| May 18, 2026 | Cao Sean Wuxiongdirector, officer: See Remarks | Sell | 21,399 | $1.99 |
| Apr 28, 2026 | Hagler Mark Arnoldofficer: See Remarks | Buy | 230,000 | $2.51 |
Source: NBP SEC Form 4 filings, latest Jul 10, 2026. For informational purposes only — not investment advice.